Medpace Holdings, Inc. (MEDP)

NASDAQ: MEDP · Real-Time Price · USD

591.29

-2.10 (-0.35%)

Sep 4, 2026, 4:00 PM EDT - Market closed

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Oncology Revenue	799.16M	747.59M	651.24M
Metabolic Revenue	905.69M	744.96M	457.54M
Other Sources of Revenue	386.25M	408.55M	431.38M
Cardiology Revenue	238.75M	239.37M	230.45M
Central Nervous System Revenue	301.87M	254.84M	181.98M
AVAI Revenue	150.56M	134.94M	156.46M
Revenue (Total)	2.78B	2.53B	2.11B

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Net New Business Awards	2.94B	2.65B	2.23B
Total Backlog	3.01B	3.03B	2.90B
Book-to-Bill Ratio	-	1.05	1.06